[Therapy of pulmonary tuberculosis].
Schmidt
M
M
Medizinische Universitätsklinik, Würzburg.
D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use*; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007297:Inpatients; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D010045:Outpatients; D011247:Pregnancy; D011515:Prothionamide / Q000627:therapeutic use; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D011718:Pyrazinamide; D011515:Prothionamide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin
Therapie der Lungentuberkulose.